Julie Yoo

This episode features interviews with payor and provider leaders about what they’re seeing and how they’re thinking about AI. Guided by Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, you’ll hear from the executives about how they’re utilizing AI, the KPIs they use to gauge effectiveness, and what they consider to be a good partnership.

Software Is Eating the World

The very nature of generative AI—conversational, scalable, accessible to non-technical users—has the potential to solve the shortcomings of previous generations of rules-based chatbots and other such products in making these concepts a reality.

Software Is Eating the World

Will is one of the few in healthcare who have successfully bridged the interface between large corporations, government, and upstarts. We are thrilled to have Will join the a16z Bio + Health team in support of our research team, portfolio companies, and ecosystem partners.

“The future is already here - it’s just unevenly distributed,” said science fiction writer William Gibson. As much as we hem and haw about the adoption of value-based care being slow, the fact is that it’s already here in various pockets, and in those pockets, it runs deep.

We believe right now is a truly transformative moment in the healthcare market—particularly in care delivery. In this article, I’ll describe some of the tailwinds that are creating this unique opportunity in health care for tech startups; what specific zones of opportunity are ripe for companies to have an impact; and some of the characteristics...

Software Is Eating the World